Class of anti-adhesion hydrogels with healing aspects

Patent metadata

Field	Value
Publication number	US-10034956-B2
Application number	US-201615283374-A
Country	US
Kind code	B2
Filing date	Oct 1, 2016
Priority date	Jan 24, 2012
Publication date	Jul 31, 2018
Grant date	Jul 31, 2018

Abstract

Disclosed are hydrogels polymerized with a biofunctional moiety, biodegradable and permanent, designed to be implantable in a mammalian body and intended to block or mitigate the formation of tissue adhesions. The hydrogels of the present invention are characterized by comprising four structural elements: a) a polymeric backbone which defines the overall polymeric morphology, b) linkage groups, c) side chains, and d) biofunctional end groups. The hydrophobicity of the various structural elements are chosen to reduce tissue adhesion and enhance the biofunctional aspect of the end groups. The morphology of these polymers are typically of high molecular weight and have shape to encourage entanglement. Useful structures include branching chains, comb or brush, and dendritic morphologies.

First claim

What is claimed is:

1. A copolymeric hydrogel comprising a polymerization product of an anionic polysaccharide, a diisocyanate, and a linker,
wherein the linker comprises i) an ether group, an ester group, or a combination thereof and, ii) a chain extender comprising a hydroxyl group, a thiol group, an amine group, or a combination thereof,
and wherein the copolymeric hydrogel comprises at least 30% by weight of water bound to the hydrogel by hydrogen bonding.

2. The copolymeric hydrogel of claim 1 , wherein the polymerization product comprises a copolymer of a prepolymer and the linker, wherein:
the prepolymer comprises a copolymer of the anionic polysaccharide and the diisocyanate.

3. The copolymeric hydrogel of claim 1 , wherein the prepolymer comprises at least one segment represented by I[UPUUPU]sI, wherein, independently for each occurrence, P represents a polysaccharide block, U represents a urethane or urea block, I represents an isocyanate and s represents and integer ranging from 1 to 10,000.

4. The copolymeric hydrogel of claim 1 , wherein the linker comprises at least one segment represented by EGE, wherein, independently for each occurrence, G represents an ether block, an ester block or a combination thereof, and E represents a chain extender comprising a hydroxyl, a thiol or an amine group.

5. The copolymeric hydrogel of claim 1 , wherein the polymerization product comprises at least one segment represented by I[UPUUPU]nUGU[UPUUPU]nI, wherein, independently for each occurrence, P represents a polysaccharide block, U represents a urea or urethane block, G represents an ether block, an ester block or a combination thereof, and s represents an integer ranging from 1 to 10,000.

6. The copolymeric hydrogel of claim 5 , further comprising at least one biofunctional molecule.

7. The copolymeric hydrogel of claim 5 , further comprising at least one biofunctional molecule.

Assignees

• Bvw Holding Ag

Inventors

• Bluecher Lukas
• Milbocker Michael

Classifications

• C08G18/3234

  cycloaliphatic · CPC title

• A61K36/324

  Boswellia, e.g. frankincense · CPC title

• A61L26/0066

  Medicaments; Biocides · CPC title

• C08G2210/00

  Compositions for preparing hydrogels · CPC title

• C08G18/65

  Low-molecular-weight compounds having active hydrogen with high-molecular-weight compounds having active hydrogen {(C08G18/2805 takes precedence)} · CPC title